Genotoxic drugs, the focus of this new study, are commonly used to treat bowel cancer by killing cancer cells through damage ...

From fast-food to ultra-processed snacks, a high-fat diet eaten over the long term may trigger biological changes in the ...

Amgen is getting down with Disco Pharmaceuticals, commissioning the German biotech to work on cancer therapies focused on a ...

Scientists at the Princeton University Branch of the Ludwig Institute for Cancer Research have identified novel mechanisms by ...

The trial met its primary endpoint with a hazard ratio of 0.75, indicating a significant reduction in disease progression ...

BostonGene has entered a new collaboration with AstraZeneca to apply its foundation AI model to oncology drug development, aiming to improve early trial decision-making around safety, efficacy, and ...

As we head into the 2026, let's take a look at biotech licensing deals and M&As that were inked in December 2025.

In Brazil, the early detection of genetic alterations in lung cancer through liquid biopsies could be a valuable tool for expediting diagnoses and guiding patient treatment.

Multi-target license agreement grants Sidewinder access to Lonza's clinically validated ADC platformSidewinder's pipeline of precision bispecific ADCs combined with Lonza's clinically validated ...